More accusations against GlaxoSmithKline are flying in China, but this time they're not about bribery. They're about taxes. A government-run legal newspaper alleges that the British drug giant evaded millions in taxes, compounding the company's growing problems in the country.
written on 19.05.2014
First, bribery. Now, China floats tax-evasion accusations against GlaxoSmithKline
